BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19293526)

  • 21. The preparation of additional smears from a cervical scrape: impact on the rate of detection of cervical neoplasia.
    Al-Awadhi R; Byrne M; Coleman DV
    Cytopathology; 2001 Jun; 12(3):151-6. PubMed ID: 11380556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution of the Papanicolaou smear.
    Tambouret RH
    Clin Obstet Gynecol; 2013 Mar; 56(1):3-9. PubMed ID: 23314726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Present standards for cervical cancer screening.
    O'Meara AT
    Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer screening: the Pap smear. Summary of an NIH consensus statement.
    Br Med J; 1980 Nov; 281(6250):1264-6. PubMed ID: 7427661
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of modified rapid economic acetic acid-based Papanicolaou stain.
    Bhagat P; Susheilia S; Singh K; Sadhukhan S; Rajwanshi A; Dey P
    Cytopathology; 2016 Dec; 27(6):452-455. PubMed ID: 27019215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematoidin crystals in Pap smear: A revisit.
    Thakur A; Sarin H
    Diagn Cytopathol; 2020 Jan; 48(1):92. PubMed ID: 31714034
    [No Abstract]   [Full Text] [Related]  

  • 29. The determination of Papanicolaou smear adequacy using a semiquantitative method to evaluate cellularity.
    Valente PT; Schantz HD; Trabal JF
    Diagn Cytopathol; 1991; 7(6):576-80. PubMed ID: 1769285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Papanicolaou smear histories of 237 patients with cervical cancer.
    Grace J
    Med J Aust; 1992 Sep; 157(5):353. PubMed ID: 1435485
    [No Abstract]   [Full Text] [Related]  

  • 31. [Factors which affect cytodiagnosis in gynecology].
    Kobilková J; Lojda Z; Dusková J; Beková A
    Cesk Patol; 2001 Jan; 37(1):10-4. PubMed ID: 11268699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why more is not always better: new Pap smear guidelines.
    Vegunta S; Kransdorf LN; Mayer AP
    J Womens Health (Larchmt); 2014 Jan; 23(1):105-6. PubMed ID: 24325612
    [No Abstract]   [Full Text] [Related]  

  • 33. The Pap smear revisited. Controversies and recent developments.
    Zuna RE
    Postgrad Med; 1984 Nov; 76(6):36-40, 42-3, 46. PubMed ID: 6494079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does speculum lubricant affect liquid-based Papanicolaou test adequacy?
    Lin SN; Taylor J; Alperstein S; Hoda R; Holcomb K
    Cancer Cytopathol; 2014 Mar; 122(3):221-6. PubMed ID: 24254917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The postpartum Papanicolaou smear.
    Weiss BD; Senf JH; Udall W
    J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papanicolaou smear: an update on classification and management.
    Fullerton JT; Barger MK
    J Am Acad Nurse Pract; 1989; 1(3):84-90. PubMed ID: 2631935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ThinPrep Pap Test. Accuracy for glandular disease.
    Ashfaq R; Gibbons D; Vela C; Saboorian MH; Iliya F
    Acta Cytol; 1999; 43(1):81-5. PubMed ID: 9987455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What should be done when the Pap smear report is 'inconclusive, possible adenocarcinoma in situ'.
    Saville M
    Pathology; 2003 Jun; 35(3):197. PubMed ID: 14506960
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro conventional cytology historical strengths and current limitations.
    Spitzer M
    Obstet Gynecol Clin North Am; 2002 Dec; 29(4):673-83. PubMed ID: 12509091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine malakoplakia diagnosed in a cervical Pap smear.
    Mirfazaelian H; Shariat M; Bedayat GR; Negahban S; Daneshbod Y
    Cytopathology; 2016 Apr; 27(2):133-4. PubMed ID: 25900733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.